Cargando…
A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis
Tuberculosis (TB) still poses a global menace as one of the deadliest infectious diseases. A quarter of the human population is indeed latently infected with Mycobacterium tuberculosis. People with latent infection have a 5 to 10% lifetime risk of becoming ill with TB, representing a reservoir for T...
Autores principales: | Salina, Elena G., Postiglione, Umberto, Chiarelli, Laurent R., Recchia, Deborah, Záhorszká, Monika, Lepioshkin, Alexander, Monakhova, Natalia, Pál, Adrian, Porta, Alessio, Zanoni, Giuseppe, Korduláková, Jana, Kazakova, Elena, Sassera, Davide, Pasca, Maria Rosalia, Makarov, Vadim, Degiacomi, Giulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769805/ https://www.ncbi.nlm.nih.gov/pubmed/36377880 http://dx.doi.org/10.1128/msphere.00369-22 |
Ejemplares similares
-
New Drugs and Novel Cellular Targets against Tuberculosis
por: Degiacomi, Giulia, et al.
Publicado: (2022) -
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients
por: Degiacomi, Giulia, et al.
Publicado: (2019) -
CanB, a Druggable
Cellular Target in Mycobacterium tuberculosis
por: Degiacomi, Giulia, et al.
Publicado: (2023) -
Existence and significance of viral nonreplicative RNA recombination
por: Agol, Vadim I.
Publicado: (2023) -
The Antimalarial Mefloquine Shows Activity against Mycobacterium abscessus, Inhibiting Mycolic Acid Metabolism
por: Degiacomi, Giulia, et al.
Publicado: (2021)